Home > Balance Sheet > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹101 Cr₹-142 Cr₹-300 Cr₹-422 Cr₹-433 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS is ₹101 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹101 Cr
Mar2023₹-142 Cr
Mar2022₹-300 Cr
Mar2021₹-422 Cr
Mar2020₹-433 Cr

How is Deferred Tax Assets / Liabilities of TORRENT PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹101 Cr
Positive
Mar2023 ₹-142 Cr
Negative
Mar2022 ₹-300 Cr
Negative
Mar2021 ₹-422 Cr
Negative
Mar2020 ₹-433 Cr -

Compare Deferred Tax Assets / Liabilities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹108,927.6 Cr 1.4% 1.3% 17% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,068.0 Cr 1.6% -2.9% 17.2% Stock Analytics
DIVIS LABORATORIES ₹177,105.0 Cr 1.5% 10.4% 51.9% Stock Analytics
CIPLA ₹122,016.0 Cr 2.3% 1.9% 2.8% Stock Analytics
DR REDDYS LABORATORIES ₹112,651.0 Cr 5.7% 14.1% 15.2% Stock Analytics
MANKIND PHARMA ₹98,130.4 Cr 0.2% -2.4% 12.5% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

1.4%

1.3%

17%

SENSEX

1.3%

2.6%

7.8%


You may also like the below Video Courses